Essilor Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 3/25/2026)
| Balance Sheet | Total Assets | 63,895,000,000.00 | ROE | 60.86 % |
| Balance Sheet | Total Equity | 38,889,000,000.00 | ROA | 3.62 % |
| Cashflow | Capital Expenditures | -1,525,000,000.00 | P/FCF | 18.26 |
| Cashflow | Free Cash Flow | 3,766,000,128.00 | – | – |
| Cashflow | Operating Cash Flow | 5,291,000,000.00 | P/CF | 13.00 |
| Income | Earnings per Share (diluted) | 5.00 | Div. Yield | 2.69 % |
| Income | Net Income | 2,315,000,000.00 | P/E | 29.70 |
| Income | Shares Outstanding | 463,190,000.00 | P/B | 1.77 |
| Income | Total Revenue | 28,491,000,000.00 | P/S | 2.41 |
Ratios calculated on: 10/14/2026
Company Description
Essilor International Compagnie Generale D'Optique SA is an ophthalmic optics company. The Company designs, manufactures and markets a range of lenses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories, and instruments and services for eye care professionals. It operates through three segments: Lenses and Optical Instruments, Equipment, and Sunglasses & Readers. It is a North American provider of non-prescription reading glasses. It also sells non-prescription sunglasses. It has approximately 32 plants, over 490 prescription laboratories, edging facilities and local distribution centers, and over five research and development centers across the world. The Company designs, manufactures and customizes corrective lenses. The Company provides a range of lenses for correcting myopia, hyperopia, astigmatism and presbyopia. The Company's flagship brands include Varilux, Crizal, Transitions, Eyezen, Xperio, Foster Grant, Bolon and Costa.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.essilor.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more